CARVONE
本记录确认了用于欧盟化妆品标签标示的官方通用成分名称。它本身并不能确认该物质获准使用、不受限制或安全。
全球证据概览
所解析的身份在 13 个已索引市场数据集中的 2 个有匹配的监管证据:1 条国家记录和 1 条欧盟附件记录。下方列出每项结果和证据缺口。
已解析的物质身份
3 个匹配或报告的名称
全部 13 个市场的监管证据
打开每条匹配记录,查看其范围、浓度、条件、警示语和官方来源版本。
滑动或横向滚动以查看数据集覆盖范围和后续操作。
| 市场 | 结果 | 记录 | 数据集 | 含义 / 后续操作 |
|---|---|---|---|---|
| European Union EU | 限用 | 1打开记录 1 | Complete annex dataset Regulation (EC) 1223/2009 consolidated to 1 May 2026 | 请查看每条关联记录及其确切条件。 |
| Great Britain GB | 未找到匹配项 | 0 | Complete consolidated annex dataset GB retained Regulation 1223/2009 schedules, effective 15 August 2026 | No annex match is not approval and does not cover Northern Ireland, which follows the applicable EU framework. |
| Canada CA | 未找到匹配项 | 0 | Complete Hotlist snapshot Health Canada Cosmetic Ingredient Hotlist, 13 August 2025 | The Hotlist is an administrative compliance tool, not an exhaustive safety approval list. |
| New Zealand NZ | 未找到匹配项 | 0 | Complete schedules dataset Cosmetic Products Group Standard schedules effective 1 January 2026 | The searchable spreadsheet is an aid; the legal Group Standard and incorporated notices remain authoritative. |
| ASEAN ASEAN | 未找到匹配项 | 0 | Complete regional annex dataset ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026 | Regional annex coverage does not replace member-state implementation dates, notifications or national deviations. |
| China CN | 未找到匹配项 | 0 | Complete prohibited catalogues plus official-source workflow NMPA 2021 banned catalogues plus dynamic IECIC List I/List II system current since 2025 | IECIC listing is not blanket approval; absence may require the new cosmetic ingredient route, and restrictions are checked separately. |
| Japan JP | 未找到匹配项 | 0 | Complete Standards appendices dataset MHLW Standards for Cosmetics official English source and Japanese amendments checked for the imported snapshot | The Japanese text and subsequent notices are canonical; no local match is not a product-compliance conclusion. |
| South Korea KR | 未找到匹配项 | 0 | Complete current appendix dataset MFDS Notice 2026-19, effective 18 March 2026 | Korean source wording is canonical and other positive lists/notices may still apply to the formulation. |
| United States US | 未找到匹配项 | 0 | Complete enumerated federal ingredient rules eCFR Title 21 issue date 27 August 2026 | FDA has no general approved-cosmetic-ingredient catalogue; absence from these sections is not approval or proof of safety. |
| Australia AU | 未找到匹配项 | 0 | Complete cosmetic-relevant Poisons Standard subset plus official workflow Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 | An AICIS Inventory match is not cosmetic approval; no Inventory match can indicate a new, exempted, reported or confidential introduction. |
| Brazil BR | 未找到匹配项 | 0 | Complete prohibited dataset plus current restricted-list workflow ANVISA RDC 1.029/2026 and RDC 1.030/2026, published 15 June 2026 | RDC 1.030/2026 amends rather than replaces the prohibited baseline, and the second restricted-list revision was still under consultation in July 2026. |
| India IN | 未找到匹配项 | 0 | Complete current Part 2 dataset plus official workflow for Parts 1, 3 and 4 Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022) | The standards are separate controlled publications; absence from a locally indexed excerpt is not permission. |
| Saudi Arabia SA | Restricted | 1打开记录 1 | Complete official list index SFDA live prohibited/restricted lists, snapshot 30 August 2026 | 请查看每条关联记录及其确切条件。 |
匹配的市场记录和条件
Saudi Arabia
SFDA live prohibited/restricted lists, snapshot 30 August 2026附件 II–VI 的精确证据
Carvone
限制: The presence of the substance shall be indicated in the list of ingredients referred to in Article 19(1), point (g), when its concentration exceeds: — 0,001 % in leave-on products — 0,01 % in rinse-off products.
化学身份与性质

Carvone, (+)-
(+)-carvone is a carvone having (S) configuration. It is an enantiomer of a (-)-carvone. — ChEBI
- IUPAC 名称
- (5S)-2-methyl-5-prop-1-en-2-ylcyclohex-2-en-1-one
- 分子式
- C10H14O
- 分子量
- 150.22 g/mol
- 精确质量
- 150.104465066 Da
- XLogP3
- 2.4
- 拓扑极性表面积
- 17.1 Ų
- 氢键供体
- 0
- 氢键受体
- 1
- 共价单元
- 1
- 已定义的立体中心
- 1
又称
另有 16 个已报告名称
外部数据库标识符
- ChEBI:CHEBI:15399
- ChEMBL:CHEMBL501949
- EPA DTXSID:DTXSID8020256
- PubMed:22746406
- PubMed:22676376
- PubMed:22606841
- PubMed:22412305
- PubMed:22303150
- PubMed:22228959
- PubMed:21931523
- PubMed:21858448
- PubMed:21736737
- PubMed:21485265
- PubMed:21428701
- PubMed:21417456
于 2026-09-02 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

Carvone, (-)-
(-)-carvone is a carvone having (R) configuration. It is an enantiomer of a (+)-carvone. — ChEBI
- IUPAC 名称
- (5R)-2-methyl-5-prop-1-en-2-ylcyclohex-2-en-1-one
- 分子式
- C10H14O
- 分子量
- 150.22 g/mol
- 精确质量
- 150.104465066 Da
- XLogP3
- 2.4
- 拓扑极性表面积
- 17.1 Ų
- 氢键供体
- 0
- 氢键受体
- 1
- 共价单元
- 1
- 已定义的立体中心
- 1
又称
另有 16 个已报告名称
外部数据库标识符
- ChEBI:CHEBI:15400
- ChEMBL:CHEMBL2229268
- EPA DTXSID:DTXSID7041413
- PubMed:22904896
- PubMed:22710980
- PubMed:22579387
- PubMed:22443782
- PubMed:22412305
- PubMed:22358424
- PubMed:22324453
- PubMed:22046188
- PubMed:21857978
- PubMed:21837043
- PubMed:21736737
- PubMed:21510630
于 2026-09-02 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

Carvone, (+-)-
Carvone is a p-menthane monoterpenoid that consists of cyclohex-2-enone having methyl and isopropenyl substituents at positions 2 and 5, respectively. It has a role as an allergen. It is a member of carvones and a botanical anti-fungal agent. — ChEBI
- IUPAC 名称
- 2-methyl-5-prop-1-en-2-ylcyclohex-2-en-1-one
- 分子式
- C10H14O
- 分子量
- 150.22 g/mol
- 精确质量
- 150.104465066 Da
- XLogP3
- 2.4
- 拓扑极性表面积
- 17.1 Ų
- 氢键供体
- 0
- 氢键受体
- 1
- 共价单元
- 1
- 已定义的立体中心
- 0
又称
另有 16 个已报告名称
外部数据库标识符
- ChEBI:CHEBI:38265
- ChEMBL:CHEMBL15676
- EPA DTXSID:DTXSID8047426
- PubMed:23449869
- PubMed:23095081
- PubMed:22871061
- PubMed:22858498
- PubMed:22799100
- PubMed:22746406
- PubMed:22710980
- PubMed:22701361
- PubMed:22654405
- PubMed:22615669
- PubMed:22518079
- PubMed:22505916
于 2026-09-02 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。
官方来源与范围
导入自委员会实施决定 (EU) 2025/1175(数据集版本 EU 2025/1175)。词汇表为第 19(1)(g) 条所要求的成分表提供通用成分名称;它不是准许清单或安全清单。
打开官方决定